Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intr
- This topic has 0 replies, 1 voice, and was last updated 5 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/30420614
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.